# FDA Inspection 1254614 - Vitalant Reference and Transfusion Service - November 14, 2024

Source: https://www.keypedia.com/records/fda_inspections/vitalant-reference-and-transfusion-service/f5186f34-ec76-493c-bf7b-e2b563a586a9
Source feed: FDA_Inspections

> FDA Inspection 1254614 for Vitalant Reference and Transfusion Service on November 14, 2024. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1254614
- Company Name: Vitalant Reference and Transfusion Service
- Inspection Date: 2024-11-14
- Classification: No Action Indicated (NAI)
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 1254614 - 2024-11-14](https://www.keypedia.com/records/fda_inspections/vitalant-reference-and-transfusion-service/4f644ad9-dea1-4071-9579-2ed661d734c4)
- [FDA Inspection 1100641 - 2019-08-08](https://www.keypedia.com/records/fda_inspections/vitalant-reference-and-transfusion-service/bb66318b-9683-4ea2-95a2-e3488430c7e3)
- [FDA Inspection 1003902 - 2017-03-09](https://www.keypedia.com/records/fda_inspections/vitalant-reference-and-transfusion-service/bf069d2d-728d-4dd8-83bd-6fdb3bc886b7)
- [FDA Inspection 907275 - 2015-01-02](https://www.keypedia.com/records/fda_inspections/vitalant-reference-and-transfusion-service/85ee317d-ff02-44b0-a6c8-a5055b663ec3)

Company: https://www.keypedia.com/companies/vitalant-reference-and-transfusion-service/6f130c39-bd6c-484a-9c4b-b24ecc52b4d1

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d